Monday, 27 November 2017

If Uber turns to self-driving vehicles, what is to become of its brand?

›
Think of the sharing economy and Uber is usually the first company that comes to mind. What could be more appropriate than providing the ...
Thursday, 23 November 2017

Tickbox TV: Concerns for Content Owners, Cable, and Silicon Valley

›
Tickbox TV provides a set top box, which allows users to access content on the internet.   Apparently, the device can be used to access ...
Wednesday, 22 November 2017

Evolution and Survival: Technology Transfer Offices

›
The Association of Land Grant and Public Universities has released a November 2017 report titled, “Technology Transfer Evolution: Driving...
Tuesday, 14 November 2017

China Changes Policy on Transfer of Technology for Market Access?

›
As previously discussed , China has been criticized for outright theft of trade secrets as well as requiring the disclosure of trade secre...
Wednesday, 8 November 2017

A pioneer in the world of university tech transfer to share his insights in a free webinar

›
IP Finance has been informed of an exciting free webinar that will take place next Wednesday, November 15, at 3:00 PM- 4:00 pm British Sta...
Tuesday, 7 November 2017

Chemical Company Joins the LOT Network Against Trolls

›
Covestro , a chemical company which uses digital technologies to build better products, has joined the LOT Network.   As previously disc...
Tuesday, 31 October 2017

Ending Soveriegn Immunity for Tribes from Inter Partes Review

›
U.S. Senator McCaskill has introduced a Bill that would remove sovereign immunity as a defense against Inter Partes Review of patents fo...
Saturday, 28 October 2017

When naming the company after yourself might make good business sense

›
For trademark professionals, dealing with a name usually means encountering an objection to registration on the ground that the surname i...
Friday, 27 October 2017

Another Case of Pharma Weakening the Patent System (and University Technology Transfer)

›
The LA Times recently published an article, "UCLA’s Efforts to Patent a Costly Patent Cancer Drug in India Hurts the Poor, Critics ...